- Previous Close
18.93 - Open
18.94 - Bid 19.11 x 300
- Ask 19.21 x 500
- Day's Range
18.71 - 19.28 - 52 Week Range
16.67 - 38.00 - Volume
609,563 - Avg. Volume
672,096 - Market Cap (intraday)
1.397B - Beta (5Y Monthly) 1.50
- PE Ratio (TTM)
-- - EPS (TTM)
-2.45 - Earnings Date Nov 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
31.91
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
www.schrodinger.com900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SDGR
View More
Performance Overview: SDGR
Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SDGR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SDGR
View MoreValuation Measures
Market Cap
1.40B
Enterprise Value
1.13B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.26
Price/Book (mrq)
3.11
Enterprise Value/Revenue
5.83
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-91.84%
Return on Assets (ttm)
-18.64%
Return on Equity (ttm)
-35.06%
Revenue (ttm)
193.35M
Net Income Avi to Common (ttm)
-177.58M
Diluted EPS (ttm)
-2.45
Balance Sheet and Cash Flow
Total Cash (mrq)
388.68M
Total Debt/Equity (mrq)
26.73%
Levered Free Cash Flow (ttm)
-100.36M
Research Analysis: SDGR
View MoreCompany Insights: SDGR
SDGR does not have Company Insights
Research Reports: SDGR
View MoreLowering target price to $15.00
SCHRODINGER INC has an Investment Rating of SELL; a target price of $15.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetRaising target price to $18.00
SCHRODINGER INC has an Investment Rating of SELL; a target price of $18.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $14.00
SCHRODINGER INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetWhat does Argus have to say about SDGR?
SCHRODINGER INC has an Investment Rating of SELL; a target price of $15.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target